Viewing StudyNCT03248531



Ignite Creation Date: 2024-05-06 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 12:29 PM
Study NCT ID: NCT03248531
Status: COMPLETED
Last Update Posted: 2022-04-11
First Post: 2017-08-02

Brief Title: A Study to Test the Efficacy Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Hidradenitis Suppurativa
Keywords:
Name View
Moderate to Severe HS View
Hidradenitis Suppurativa View
Bimekizumab View
HS View